HSA in block letters with rolled up currency on top In 2019, the IRS tweaked coverage to allow certain drugs to treat chronic conditions to be covered pre-deductible. (Photo: Shutterstock)

A recent regulatory change expanding the number of medications included for pre-deductible coverage did not result in significantly increased insurance premiums, a new study has found.

The report from the Employee Research Benefits Institute (EBRI) looked at a regulation change from 2019 that expanded the list of pre-deductible drugs to include several that address chronic diseases. The change by the IRS allowed Health Savings Account (HSA)-eligible health plans to provide pre-deductible coverage to 14 medications and services that treat chronic illnesses.

Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.

Your access to unlimited BenefitsPRO.com content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

Already have an account?



Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.